Nonfluoroscopic endoventricular electromechanical three-dimensional mapping: current status and future perspectives.

Jpn Circ J

Department of Interventional Cardiology, Thoraxcenter Rotterdam, Academic Hospital Dijkzigt, Erasmus University, The Netherlands.

Published: August 2001

Download full-text PDF

Source
http://dx.doi.org/10.1253/jcj.65.695DOI Listing

Publication Analysis

Top Keywords

nonfluoroscopic endoventricular
4
endoventricular electromechanical
4
electromechanical three-dimensional
4
three-dimensional mapping
4
mapping current
4
current status
4
status future
4
future perspectives
4
nonfluoroscopic
1
electromechanical
1

Similar Publications

Aim: Biological therapies for ischaemic heart disease require efficient, safe, and affordable intramyocardial delivery. Integration of multiple imaging modalities within the fluoroscopy framework can provide valuable information to guide these procedures. We compared an anatomo-electric method (LARCA) with a non-fluoroscopic electromechanical mapping system (NOGA(®)).

View Article and Find Full Text PDF

Combined analysis of the electrical and mechanical function of the heart holds promise as a means of acquiring a better understanding of a variety of cardiac diseases that ultimately may lead to heart failure. The NOGA XP Cardiac Navigation System is a unique, nonfluoroscopic, catheter-based technology that achieves real-time acquisition of three-dimensional, endoventricular electromechanical maps. Through the provision of point-by-point measurements of endocardial electrical activation and voltage and mechanical shortening, electromechanical mapping has been evaluated for its ability to identify regional myocardial ischemia and characterize tissue viability.

View Article and Find Full Text PDF

Background: Recently, a novel nonfluoroscopic 3-dimensional electromechanical mapping technique was introduced in the clinical arena. Although initial in vitro and in vivo studies suggested the reliability of the system in volumetric and hemodynamic evaluation of the left ventricle, no validation in human beings has been performed.

Methods: A nonfluoroscopic electromechanical mapping (NOGA, Biosense-Webster) procedure was performed in 44 patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!